JOSHOA A KAZAM Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOSHOA A KAZAM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOSHOA A KAZAM. JOSHOA A KAZAM is Director in TG THERAPEUTICS, INC. ($TGTX) and Director in CAPRICOR THERAPEUTICS, INC. ($CAPR) and Director in Kite Pharma, Inc. ($KITE) and Director in Platinum Eagle Acquisition Corp. ($EAGL) and in Allogene Therapeutics, Inc. ($ALLO) and Director in Allogene Therapeutics, Inc. ($ALLO) and Director in Kronos Bio, Inc. ($KRON) and Director in Diamond Eagle Acquisition Corp. \ DE ($DEAC).
Latest Insider Trading Transactions of JOSHOA A KAZAM
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALLO, CAPR, DKNG, KITE, KRON, EAGL, TGTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Gift | G | 0.00 | 500,000 | 0 | 243,885 | 743.9 K to 243.9 K (-67.21 %) | |
Jun 11 2021 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Grant | A | 0.00 | 16,498 | 0 | 743,885 | 727.4 K to 743.9 K (+2.27 %) | |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Kazam Joshua A | Director | Option Exercise | C | 0.00 | 65,228 | 0 | 0 | |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Kazam Joshua A | Director | Option Exercise | C | 0.00 | 22,328 | 0 | 0 | |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Kazam Joshua A | Director | Buy | C | 0.00 | 68,815 | 0 | 94,481 | 25.7 K to 94.5 K (+268.12 %) |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Kazam Joshua A | Director | Option Exercise | C | 0.00 | 65,228 | 0 | 0 | |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Kazam Joshua A | Director | Buy | C | 0.00 | 23,556 | 0 | 25,666 | 2.1 K to 25.7 K (+1,116.40 %) |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Kazam Joshua A | Director | Option Exercise | C | 0.00 | 22,328 | 0 | 0 | |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Kazam Joshua A | Director | Buy | C | 0.00 | 68,815 | 0 | 94,481 | 25.7 K to 94.5 K (+268.12 %) |
Oct 16 2020 | KRON | Kronos Bio, Inc. | Kazam Joshua A | Director | Buy | C | 0.00 | 23,556 | 0 | 25,666 | 2.1 K to 25.7 K (+1,116.40 %) |
Apr 28 2020 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Buy | J | 0.00 | 8,039 | 0 | 1,023,336 | 1 M to 1 M (+0.79 %) | |
Mar 11 2020 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Buy | J | 0.00 | 8,217 | 0 | 1,015,297 | 1 M to 1 M (+0.82 %) | |
Dec 31 2019 | DEAC | Diamond Eagle Acqu ... | Kazam Joshua A | Director | Option Exercise | J | 0.00 | 20,000 | 0 | 20,000 | |
Nov 21 2019 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Gift | G | 0.00 | 446,623 | 0 | 1,007,080 | 1.5 M to 1 M (-30.72 %) | |
Nov 21 2019 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Buy | J | 0.00 | 8,217 | 0 | 1,453,703 | 1.4 M to 1.5 M (+0.57 %) | |
Oct 29 2019 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Buy | J | 0.00 | 8,217 | 0 | 1,445,486 | 1.4 M to 1.4 M (+0.57 %) | |
Sep 25 2019 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Buy | J | 0.00 | 8,217 | 0 | 1,437,269 | 1.4 M to 1.4 M (+0.57 %) | |
Sep 09 2019 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Buy | J | 0.00 | 8,217 | 0 | 1,429,052 | 1.4 M to 1.4 M (+0.58 %) | |
Jul 22 2019 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Director | Buy | J | 0.00 | 8,217 | 0 | 1,420,835 | 1.4 M to 1.4 M (+0.58 %) |
Jul 12 2019 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Director | Buy | J | 0.00 | 5,590 | 0 | 1,412,618 | 1.4 M to 1.4 M (+0.40 %) |
Jun 24 2019 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Director | Grant | A | 0.00 | 16,377 | 0 | 1,407,028 | 1.4 M to 1.4 M (+1.18 %) |
Mar 05 2019 | EAGL | Platinum Eagle Acq ... | Kazam Joshua A | Director | Buy | P | 10.20 | 5,000 | 51,000 | 10,000 | 5 K to 10 K (+100.00 %) |
Mar 01 2019 | EAGL | Platinum Eagle Acq ... | Kazam Joshua A | Director | Buy | P | 10.13 | 5,000 | 50,650 | 5,000 | 0 to 5 K |
Jan 22 2019 | EAGL | Platinum Eagle Acq ... | Kazam Joshua A | Director | Option Exercise | P | 0.00 | 20,000 | 0 | 20,000 | |
Oct 17 2018 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Director | Option Exercise | C | 0.00 | 3,565 | 0 | 0 | |
Oct 17 2018 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Director | Buy | C | 0.00 | 18,716 | 0 | 1,390,651 | 1.4 M to 1.4 M (+1.36 %) |
Jan 18 2018 | EAGL | Platinum Eagle Acq ... | Kazam Joshua A | Director | Option Exercise | A | 11.50 | 333,334 | 3,833,341 | 333,334 | |
Jan 04 2018 | CAPR | CAPRICOR THERAPEUT ... | Kazam Joshua A | Director | Option Exercise | A | 1.57 | 18,000 | 28,260 | 18,000 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | D | 91.21 | 8,810 | 803,560 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | D | 50.87 | 7,000 | 356,090 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | D | 59.23 | 10,000 | 592,300 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | D | 1.35 | 50,000 | 67,500 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Sell | D | 0.00 | 1,807 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Sell | U | 180.00 | 2,553 | 459,540 | 1,807 | 4.4 K to 1.8 K (-58.56 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Sell | D | 180.00 | 70,050 | 12,609,000 | 0 | 70.1 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Buy | J | 0.00 | 70,050 | 0 | 70,050 | 0 to 70.1 K |
Jun 22 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
Jun 22 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Grant | A | 0.00 | 2,410 | 0 | 4,360 | 2 K to 4.4 K (+123.59 %) |
Jan 04 2017 | CAPR | CAPRICOR THERAPEUT ... | Kazam Joshua A | Director | Option Exercise | A | 2.55 | 16,060 | 40,953 | 16,060 | |
Jun 06 2016 | CAPR | CAPRICOR THERAPEUT ... | Kazam Joshua A | Director | Option Exercise | A | 3.12 | 15,000 | 46,800 | 15,000 | |
Jun 03 2016 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | A | 50.87 | 7,000 | 356,090 | 7,000 | |
Jun 03 2016 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Grant | A | 0.00 | 1,950 | 0 | 216,950 | 215 K to 217 K (+0.91 %) |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | A | 59.23 | 10,000 | 592,300 | 10,000 | |
Mar 05 2015 | CAPR | CAPRICOR THERAPEUT ... | Kazam Joshua A | Director | Option Exercise | A | 5.78 | 7,500 | 43,350 | 7,500 | |
Feb 02 2004 | TGTX | TG THERAPEUTICS, I ... | KAZAM JOSHOA A | Director | Option Exercise | A | 1.65 | 75,000 | 123,750 | 85,173 | |
Feb 02 2004 | TGTX | TG THERAPEUTICS, I ... | KAZAM JOSHOA A | Director | Option Exercise | J | 1.21 | 60,173 | 72,809 | 85,173 |
Page: 1